Inivata is a leader in liquid biopsy. Our InVision® platform unlocks essential genomic information from a simple blood draw.
Cambridge, UK and RTP, USA
Joined September 2014
- Tweets1.5K
- Following1.1K
- Followers1.1K
- Likes954
Inivata retweeted
In this #openaccess article in Annals of Oncology, the investigators assessed the outcome of patients treated for stage I-III #NSCLC 🫁 who had serial plasma sampling after completion of therapy with curative intent.
annalsofoncology.org/article…
@rintoul_robert
@inivata
#LCSM
Inivata retweeted
Patients who are at a higher risk of their #LungCancer returning can be identified by a personalised blood test performed after treatment, according to new research from our Rosenfeld Group and @rintoul_robert @RoyalPapworth.
Find out more 👉cruk.cam.ac.uk/2022/03/17/pe…
Inivata retweeted
The results on ctDNA (LUCID-DNA study) have been published today in the Annals of Oncology.
Prof Robert Rintoul, co-lead author: "These results clearly show that liquid biopsies can potentially help decide which patients need further treatment."
annalsofoncology.org/article…
Inivata retweeted
Aart was one of our patients who participated in the research study following #LungCancer surgery.
“Fortunately my original lung cancer has not returned. I was very pleased to be able to help with this research to increase the chance of curing more people.”
@CRUK_CI | @Inivata
ALT Two people sitting in chairs in a hospital clinic room, wearing masks.
Inivata retweeted
#ClinicalStudies
~@Revive_RVV provides an update on phase 3 #ClinicalTrial for #Bucillamine in #COVID19
~@lungpacer accelerates pivotal #ClinicalStudy with
AeroPace™ System
~@Inivata study highlights #liquidbiopsy potential in #HNSCC disease detection
ALT Image Source: https://www.bioworld.com/topics/85-bioworld-medtech
Inivata retweeted
#BRCtenantNews @Inivata attended the recent #ESMO21 virtual congress. Here Dr Mike Nahorski, Director of Clinical and Scientific Alliances shares the #liquidbiopsy highlights from the event ow.ly/X2sD50Gqha3
Inivata retweeted
"Cancer care has seen a rapid evolution toward what has become known as precision medicine. Precision medicine is a model where the care plan is customized to each patient and the unique hallmarks driving their cancer." Continue reading: lnkd.in/dBRiV-vc
Inivata retweeted
We put patients first at NeoGenomics. Fast test results and reliable information are crucial for treating advanced non-small cell lung cancer patients. We offer the InVisionFirst®-Lung Liquid Biopsy Assay with a 5-day turnaround time for molecular results: lnkd.in/db6dyupr
Inivata retweeted
East of England BioMedTech companies have been involved in deals worth more than $50 billion in the first five months of 2021, raised in style and at a fair clip. bit.ly/3bEFukl @Inivata @KymabLtd @sanofi @GyroscopeTx @achillestx @Mogrify_UK @PhoreMostLtd @sensedx1
Inivata retweeted
Precision cancer diagnostics company @Inivata agrees to $390m acquisition by @NeoGenomics, offering exits to @IPGroupplc and @cic_vc globaluniversityventuring.co…
Inivata retweeted
NeoGenomics Inc has exercised its right to hoover up the whole of Cambridge liquid biopsy specialist @Inivata. Having made a $25m minority investment in Inivata, @NeoGenomics has taken up a fixed price option to buy the remainder for a further $390m. bit.ly/3xM1XoW
Inivata retweeted
@NeoGenomics Inc (NASDAQ: NEO) has agreed to acquire CIC portfolio company @Inivata. By combining NeoGenomic’s leadership in cancer diagnostics with Inivata’s ground-breaking #cancer management technology, this acquisition represents a significant milestone in the sector
#MRD
Inivata retweeted
#BRCtenantNews This fabulous animation tells the story of @Inivata and how #LiquidBiopsy is helping guide more informed treatments for #cancer patients.
ow.ly/vR7N50E0ahA
Inivata retweeted
Many people are now aware that a cough could be covid, but it could also be lung cancer. As well as a cough, there are a few other vital lung cancer symptoms that you may not be aware of.
roycastle.org/5-lung-cancer-…
Inivata retweeted
Precision cancer diagnostics company @Inivata has grown its series C to $60m following an extension backed by @IPGroupplc globaluniversityventuring.co…
Inivata retweeted
Ahead of #WorldCancerDay tomorrow, we are urging people with possible lung cancer symptoms to go to their doctor.
If you have a persistent cough like Anne did, it could be a symptom of lung cancer and you should make an appointment with your GP.
Inivata retweeted
Incredibly grateful for the opportunity to work on this project with our collaborators and the mentorship I’ve received here at @WashUIMRes! #WCLC20 @SitemanCenter @Inivata @WUSTLmed
Some very interesting data presented at #WCLC20 Singapore by @BrendanJKnapp, Resident Physician at @WUSTL, on the feasibility of using #ctDNA testing to identify locally advanced #NSCLC patients who are at a high risk of recurrence…
Inivata retweeted
@Inivata today announces that the first patients have been tested using InVisionFirst®-Lung as part of the Phase II ALKALINE trial sponsored by @EORTC
More info: ow.ly/Xv7X50Dd8kw
#LungCancer #LCSM